Drug Type Small molecule drug |
Synonyms Chlorpromazine phenolphthalinate (JAN), Wintermin, ウインタミン |
Mechanism ADRA2 antagonists(Adrenergic receptors alpha-2 antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists), Histamine receptor antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (01 Jan 1977), |
Regulation- |
Molecular FormulaC37H35ClN2O4S |
InChIKeyZRZQLIGMSARLBW-UHFFFAOYSA-N |
CAS Registry102974-44-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04034 | Chlorpromazine Phenolphthalinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Mania | JP | 07 Aug 1997 | |
Neurotic Disorders | JP | 07 Aug 1997 | |
Nausea and vomiting | JP | 07 Jul 1977 | |
Anesthesia | JP | 01 Jan 1977 | |
Anxiety Disorders | JP | 01 Jan 1977 | |
Bipolar Disorder | JP | 01 Jan 1977 | |
Depressive Disorder | JP | 01 Jan 1977 | |
Nausea | JP | 01 Jan 1977 | |
Schizophrenia | JP | 01 Jan 1977 | |
Sedation | JP | 01 Jan 1977 | |
Seizures | JP | 01 Jan 1977 |